BPG致力于知识发现和传播
Articles Published Processes
2021/3/28 15:54:48 | Browse: 315 | 下载: 625
| Publication Name |
世界华人消化杂志 |
| 手稿编号 |
38076 |
| 手稿来源省、自治区或特别行政区 |
浙江省 |
 |
Received |
|
2020-12-15 10:52 |
|
Peer-Review Started |
|
2020-12-16 07:31 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-01-15 00:04 |
|
修回稿 |
|
2021-01-20 08:21 |
|
Second Decision |
|
2021-02-26 08:47 |
|
期刊总编辑接受 |
|
|
|
公司总编辑接受 |
|
2021-03-03 05:39 |
|
预出版 |
|
2021-03-03 05:39 |
|
缴纳版面费 |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
排版 |
|
2021-03-27 04:50 |
|
在线出版 |
|
2021-03-28 15:54 |
| ISSN |
1009-3079 (print) and 2219-2859 (online) |
| 开放获取 |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| 版权 |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| 网址 |
http://www.wjgnet.com |
| 专业类型 |
消化外科学 |
| 手稿栏目类型 |
临床研究 |
| 文章标题 |
伊立替康辅助FOLFOX化疗方案对结直肠癌患者血清肿瘤标志物及miR-200a、miR-190含量的影响
|
| 手稿来源 |
自由来稿 |
| 所有作者列表 |
吴林峰, 郑梦梦, 陈伟克, 肖荣耀 |
| ORCID |
|
| 基金项目及其编号 |
|
| 通讯作者 |
吴林峰, 研究生, 主治医师, 325000, 浙江省温州市鹿城区锦绣路75号, 温州市中西医结合医院肿瘤科. rengzhongxiewe@163.com |
| 关键词 |
结直肠癌; 伊立替康; FOLFOX; 肿瘤标志物; miR-200a; miR-190 |
| 核心内容提要 |
结直肠癌的化疗仍是主要的治疗方式, FOLFOX属于比较经典的治疗方案是治疗结直肠癌的首选. 同时, 伊立替康在抑制肿瘤生长, 促进细胞凋亡方面有较显著的效果. 本研究采用伊立替康联合FOLFOX的化疗方案对结直肠癌进行治疗, 分别从肿瘤控制率, 血清肿瘤标志物、miR-200a、miR-190的变化, 以及毒副反应、生存率等几个方面证实其相较单一化疗药物的疗效优势. 为结直肠癌的联合用药治疗提供临床借鉴. |
| 出版日期 |
2021-03-28 15:54 |
| 引文著录 |
吴林峰, 郑梦梦, 陈伟克, 肖荣耀. 伊立替康辅助FOLFOX化疗方案对结直肠癌患者血清肿瘤标志物及miR-200a、miR-190含量的影响. 世界华人消化杂志 2021; 29(6): 299-305 |
| URL |
https://www.wjgnet.com/1009-3079/full/v29/i6/299.htm |
| DOI |
https://dx.doi.org/10.11569/wcjd.v29.i6.299 |
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
